Dr. Reddy's Laboratories Limited
Headquarters country
India
Registry sponsor category
Industry
- Company name
- Dr. Reddy's Laboratories Limited
- Organisation type
- Industry
- Registered legal name
- DR. REDDY'S LABORATORIES LIMITED
- Registry sponsor category
- Industry
- Website
- http://www.drreddys.com/
- Legal Entity Identifier (LEI)
- 335800OVDPY3DVZR2798
- Wikidata ID
- Q908961
Related records
Subsidiaries (1)
- Aurigene Discovery Technologies Limited Direct subsidiary
Trials (239)
- A Bioavailability Study of DFD-03 Compared to Tazorac® in Patients With Moderate Acne Vulgaris
- A Comparative Bioavailability Study of DFD-29 Capsules 40 mg Versus SOLODYN® Tablets 105 mg, Under Fasting & Fed Conditions in Healthy Adult Human Subjects
- A Comparative, Crossover, Pharmacokinetic, Pharmacodynamic and Safety Study of Three Forms of PEG-G-CSF in Normal Healthy Volunteers
- A Controlled Study to Assess the Efficacy, Safety and Tolerability of Oral DFD-29 Extended Release Capsules
- A Pediatric Safety and Pharmacokinetics Study of Ha44 Gel Administered Topically for Treatment of Head Lice Infestation
- A Phase III Transition Study of DRL Rituximab to Reference Medicinal Products
- A Randomized, Double-Blind Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea.
- A Safety and Efficacy Study of DRL-17822, a Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Patients With Abnormal Cholesterol Levels
- A Safety, Tolerability and Pharmacokinetic Study of Two Formulations of Metronidazole Versus Immediate Release Metronidazole in Patient With C. Difficile Colitis
- A Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
- A Study of the Safety and Efficacy of DFD-03 for the Treatment of Acne Vulgaris
- A Study of the Safety and Efficacy of DFD-03 Lotion in the Treatment of Acne Vulgaris for 12 Weeks
- A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
- A Study to Assess the Efficacy and Safety of XP23829 in Subjects With Moderate-to-Severe Chronic Plaque-Type Psoriasis
- A Study to Assess the Efficacy, Safety and Tolerability of DFD-04
- A Study to Assess the Safety and Local Tolerability of DFD-03 (Tazarotene) Lotion, 0.1% Compared to Tazorac® Cream, 0.1% in the Topical Treatment of Acne Vulgaris
- A Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea (MVOR-2)
- A Study to Evaluate Pharmacokinetics of DRL_AB in Healthy Male Participants
- A Study to Evaluate the Therapeutic Equivalence of Generic Permethrin Cream 5% to Elimite® in the Treatment of Scabies
- A Study to Evaluate Two Concentrations of DFD-07 Cream, in Subjects With Actinic Keratosis (AK) of the Face and/or Scalp Over a 12-week Treatment Period